Sartar Therapeutics: A New Precision Therapy for Rare Soft Tissue Cancers
Accelerating the Bioeconomy: Microbes as a Sustainable Alternative to Synthetic Nitrogen Fertilizers
Biotech Experts in Finland: Tuuli Pietilä, Blueprint Genetics
Finnish Bioindustries warmly welcomes Synbio Powerlabs as its newest member!
3PBIOVIAN strengthens its Leadership team with the appointment of a Business Development Director for Advanced Therapies
A new global gene therapy manufacturing facility boosts healthcare innovation in Finland
AP-HP has selected Aiforia as a partner for AI-assisted pathology image analysis
Herantis Pharma announces approval of clinical trial application for a Phase 1b trial with HER-096 in Parkinson’s disease
DevCo Partners Announce Strategic Capital Raise for Medix Biochemica
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine
Aiforia: AI Revolution in Pathology
From Target Discovery to Precision Medicine – the Unique Potential of Finnish Biobanks in Biomedical Research, 30 September 2024
